Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionFifth Third Bancorp
Latest Disclosed Ownership5,501 shares
Latest Disclosed Value $ 1,098,271
Fifth Third Bancorp reports 3,519.08% increase in ownership of LGND / Ligand Pharmaceuticals Incorporated

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 5,501 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $1,098,275 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 152 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 3,519.08% during the quarter. The current value of the position is $1,289,434 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,501 5,349 3,519.08 1,098 3,821.43 0.0020
2026-02-02 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 152 7 4.83 29 12.00 0.0001
2025-11-07 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 145 27 22.88 26 92.31 0.0001
2025-07-15 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 118 -7 -5.60 13 0.00 0.0000
2025-04-15 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 125 38 43.68 13 44.44 0.0000
2025-01-21 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 87 -27 -23.68 9 -18.18 0.0000
2024-10-17 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 114 5 4.59 11 22.22 0.0000
2024-07-22 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 109 11 11.22 9 28.57 0.0000
2024-04-23 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 98 0 0.00 7 16.67 0.0000
2024-01-19 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 98 -55 -35.95 7 -33.33 0.0000
2023-10-31 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 153 25 19.53 9 0.00 0.0000
2023-07-26 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 128 3 2.40 9 0.00 0.0000
2023-04-24 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 125 52 71.23 9 125.00 0.0000
2023-01-25 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 73 32 78.05 5 0.00 0.0000
2022-10-25 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 41 -27 -39.71 4 -33.33 0.0000
2022-08-04 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 68 18 36.00 6 0.00 0.0000
2022-04-19 2022-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 50 -4,861 -98.98 6 -99.21 0.0000
2022-02-01 2021-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,911 4,824 5,544.83 759 6,225.00 0.0030
2021-10-15 2021-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 87 -148 -62.98 12 -61.29 0.0001
2021-08-06 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 235 -56 -19.24 31 -29.55 0.0001
2021-05-07 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 291 -264 -47.57 44 -20.00 0.0002
2021-02-16 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 555 -2,880 -83.84 55 -83.18 0.0003
2020-11-09 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,435 -1,234 -26.43 327 -37.36 0.0018
2020-08-05 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,669 212 4.76 522 61.11 0.0031
2020-05-05 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,457 401 9.89 324 -23.40 0.0023
2020-02-14 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,056 -149 -3.54 423 0.95 0.0024
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,205 580 16.00 419 1.21 0.0025
2019-08-07 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,625 276 8.24 414 -1.66 0.0025
2019-05-14 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,349 159 4.98 421 -2.77 0.0027
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,190 787 32.75 433 -34.39 0.0031
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 2,403 -636 -20.93 660 4.76 0.0042
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,039 -757 -19.94 630 0.48 0.0043
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 3,796 -1,016 -21.11 627 -4.86 0.0043
2018-02-14 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,812 274 6.04 659 6.63 0.0045
2017-11-14 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,538 -559 -10.97 618 -0.16 0.0044
2017-08-11 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,097 67 1.33 619 16.35 0.0046
2017-05-12 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,030 -424 -7.77 532 -3.97 0.0040
2017-02-13 2016-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 5,454 -35 -0.64 554 -1.07 0.0045
2017-02-09 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,489 0 560 0.0046
2016-11-10 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,489 -190 -3.35 560 -17.28 0.0046
2016-08-11 2016-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,679 -922 -13.97 677 -4.24 0.0057
2016-05-13 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,601 -7 -0.11 707 -1.26 0.0061
2016-02-16 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,608 -446 -6.32 716 18.54 0.0063
2015-11-13 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 7,054 668 10.46 604 -6.21 0.0056
2015-08-14 2015-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,386 -2,736 -29.99 644 -8.39 0.0056
2015-05-14 2015-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 9,122 967 11.86 703 61.98 0.0061
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 8,155 2,405 41.83 434 60.74 0.0037
2014-11-17 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,750 -302 -4.99 270 -28.38 0.0025
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,052 4,122 213.58 377 190.00 0.0034
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 1,930 1,930 130 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.